We know that many of the best ideas can come from outside of GSK, and collaborating with other companies, organizations, nonprofits/NGOs, and academics is a fundamental part of our business strategy.
We are committed to working with partners to deliver innovative new medicines, vaccines, and consumer healthcare products, and to develop new ways of working.
GSK/Save the Children partnership
We have an innovative ten-year partnership with Save the Children to help save one million children’s lives. We are combining GSK’s scientific and manufacturing expertise with Save the Children’s on-the-ground experience to find new ways to help bring down the number of children dying from preventable and treatable diseases. In the next few years, by focusing on running long-term health programmes, strengthening countries’ healthcare systems, finding new treatments and advocating for global change, we can help build a world where no child under the age of five dies from preventable causes.
To date, we have reached over 2.98 million children in 46 countries through our partnership. Over 114,000 children under-five have been fully immunised and over 282,000 children have been treated for diarrhoea, malaria or pneumonia. GSK employees have also fundraised over £4m for Save the Children, which is matched by GSK.